Atea Pharmaceuticals director proposes $35.2K sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Atea Pharmaceuticals, Inc. (AVIR) lists a Form 144 notice for director Bruce Polsky to sell 8,720 common shares, with an aggregate market value of $35,155.55 and an approximate sale date of November 17, 2026. The notice also reports that he sold 14,254 common shares on November 16, 2026, for gross proceeds of $60,840.35 during the preceding three months.
Key Figures
Key Terms
Aggregate Market Value financial
Stock Option Exercise technical
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.